SGN-CD123A

Seattle Genetics Initiates Phase 1 Trial of SGN-CD123A for Patients with Relapsed or Refractory Acute Myeloid Leukemia
Yahoo
Mon, 09/19/16 - 09:51 am
Seattle Genetics
clinical trials
SGN-CD123A
AML
acute myeloid leukemia